Improving Health, Health Care and Quality of Life

DaVita Enhances Already Strong Governance Policies

DENVER, Mar 14, 2011 (BUSINESS WIRE) --

The Board of Directors (the "Board") of DaVita Inc. (NYSE: DVA) today announced that it has enhanced the company's already strong corporate governance policies and practices.

 

Over the past year, the Board has undertaken a thorough evaluation of the company's corporate governance structure in light of shareholder sentiment and corporate governance trends. As a result of this process the Board has:

 

  • Amended the company's bylaws to grant the right to call a special meeting to shareholders who hold 10% or more of the company's outstanding shares of common stock.
  • Approved terminating the company's existing rights agreement ("poison pill") that was due to expire in November 2012. The Board concurrently adopted a policy that the company would not adopt a non-shareholder approved poison pill, subject to certain limited circumstances.
  • Changed the company's corporate governance guidelines to set a mandatory retirement age of 75 for Board members and limit Board members to serving on no more than 4 other public company boards.
  • Implemented a clawback policy providing for the recoupment by the company of certain incentive compensation of Board members or executive officers in the event that the company has to restate all or a portion of its financial statements and if such Board members' or officers' wrongful conduct contributed to the company's having to restate.

 

The company's Lead Independent Director Peter Grauer said, "The decision to implement these governance changes further reinforces our already strong governance practices and reflects our commitment to sound corporate governance policies and practices."

About DaVita

DaVita Inc., a Fortune 500(R) company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease. As of Dec. 31, 2010, DaVita operated or provided administrative services at 1,612 dialysis facilities, serving approximately 125,000 patients. DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. The company's leadership development initiatives and corporate social responsibility efforts have been recognized by FortuneModern Healthcare,Newsweek and WorldBlu, among others. For more information, please visit www.davita.com.

SOURCE: DaVita Inc.

DaVita Inc.
Investors:
Jim Gustafson, 310-536-2585
Jim.Gustafson@davita.com

Contact Investor Relations

For media inquiries, please contact:

Media Kit

Kate Stabrawa
2000 16th Street
Denver, CO 80202
(303) 876-7527